Arbutus Reports Second Quarter 2022 Financial Results and Provides Corporate Update
04 août 2022 07h30 HE
|
Arbutus Biopharma Corporation
Key milestones across our chronic hepatitis B virus (cHBV) and pan-coronavirus programs remain on track Financially strong with a projected cash runway into the second quarter of 2024 Conference...